000 01672 a2200457 4500
005 20250516123408.0
264 0 _c20130520
008 201305s 0 0 eng d
022 _a2072-6651
024 7 _a10.3390/toxins4111058
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiguel, Antonio
245 0 0 _aComparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model.
_h[electronic resource]
260 _bToxins
_cOct 2012
300 _a1058-81 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aB7-2 Antigen
_xgenetics
650 0 4 _aCancer Vaccines
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aGene Transfer Techniques
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xgenetics
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aMelanoma, Experimental
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeoplasm Transplantation
650 0 4 _aSurvival Analysis
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aTransfection
700 1 _aHerrero, María José
700 1 _aSendra, Luis
700 1 _aBotella, Rafael
700 1 _aAlgás, Rosa
700 1 _aSánchez, Maria
700 1 _aAliño, Salvador F
773 0 _tToxins
_gvol. 4
_gno. 11
_gp. 1058-81
856 4 0 _uhttps://doi.org/10.3390/toxins4111058
_zAvailable from publisher's website
999 _c22310642
_d22310642